Garufi, G.; Carbognin, L.; Schettini, F.; SeguÃ, E.; Di Leone, A.; Franco, A.; Paris, I.; Scambia, G.; Tortora, G.; Fabi, A.
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents. Cancers 2022, 14, 4064.
https://doi.org/10.3390/cancers14174064
AMA Style
Garufi G, Carbognin L, Schettini F, Seguà E, Di Leone A, Franco A, Paris I, Scambia G, Tortora G, Fabi A.
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents. Cancers. 2022; 14(17):4064.
https://doi.org/10.3390/cancers14174064
Chicago/Turabian Style
Garufi, Giovanna, Luisa Carbognin, Francesco Schettini, Elia SeguÃ, Alba Di Leone, Antonio Franco, Ida Paris, Giovanni Scambia, Giampaolo Tortora, and Alessandra Fabi.
2022. "Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents" Cancers 14, no. 17: 4064.
https://doi.org/10.3390/cancers14174064
APA Style
Garufi, G., Carbognin, L., Schettini, F., SeguÃ, E., Di Leone, A., Franco, A., Paris, I., Scambia, G., Tortora, G., & Fabi, A.
(2022). Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents. Cancers, 14(17), 4064.
https://doi.org/10.3390/cancers14174064
